<i>RIPK1</i> Expression Associates With Inflammation in Early Atherosclerosis in Humans and Can Be Therapeutically Silenced to Reduce NF-κB Activation and Atherogenesis in Mice

Denuja Karunakaran(The University of Queensland), Katey J. Rayner(University of Ottawa), Janine M. van Gils(Leiden University Medical Center), Aldons J. Lusis(ABT Molecular Imaging (United States)), Adil Rasheed(University of Toronto), Liang Guo(CVPath Institute), Dianne Vreeken(Erasmus MC), Richard G. Jung(University of Ottawa), Ljubica Matic(Karolinska University Hospital), Hailey Wyatt(Yale University), Nicola Otte(The University of Queensland), Joshua W. Kandiah(MACOM (United States)), Calvin Pan(Laboratory of Molecular Genetics), My-Anh Nguyen(University of Ottawa), Ulf Hedin(Karolinska Institutet), Frank D. Kolodgie(Howard Hughes Medical Institute), Emma Gordon(The University of Queensland), Renu Virmani(CVPath Institute), Michèle Geoffrion(University of Ottawa), Jason E. Fish(University of California, San Francisco), Ana Mompeón(Northwestern University), Henry S. Cheng(Brigham and Women's Hospital), Patricia Essebier(The University of Queensland), Peter Liu(Genomic Health (United States)), Zachary Lister(MACOM (United States)), Richard Lee(Ionis Pharmaceuticals (United States)), Francis J. Alenghat(Boston Children's Hospital)
Circulation
November 23, 2020
Cited by 233


Related Papers